clonidine has been researched along with cgp 37849 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Maj, J; Rogóz, Z; Skuza, G | 1 |
Brugger, F; Chambers, JP; Evans, RH; Faber, ES | 1 |
2 other study(ies) available for clonidine and cgp 37849
Article | Year |
---|---|
Some central effects of CGP 37849 and CGP 39551, the competitive NMDA receptor antagonists: potential antiparkinsonian activity.
Topics: 2-Amino-5-phosphonovalerate; alpha-Methyltyrosine; Animals; Antiparkinson Agents; Antipsychotic Agents; Biogenic Monoamines; Catalepsy; Central Nervous System Agents; Clonidine; Levodopa; Male; Methyltyrosines; Motor Activity; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Reserpine; Tyrosine 3-Monooxygenase | 1993 |
Depression of A and C fibre-evoked segmental reflexes by morphine and clonidine in the in vitro spinal cord of the neonatal rat.
Topics: 2-Amino-5-phosphonovalerate; Action Potentials; Analgesics, Opioid; Animals; Animals, Newborn; Clonidine; Excitatory Amino Acid Antagonists; Morphine; Rats; Rats, Sprague-Dawley; Spinal Cord | 1997 |